PCN197 - COST UTILITY ANALYSIS OF FIRST-LINE PACLITAXEL WITH CARBOPLATIN AND BEVACIZUMAB FOLLOWED BY MAINTENANCE BEVACIZUMAB VERSUS PEMETREXED WITH CARBOPLATIN FOLLOWED BY MAINTENANCE PEMETREXED IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SM ...

Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.279
https://www.valueinhealthjournal.com/article/S1098-3015(18)33579-4/fulltext
Title : PCN197 - COST UTILITY ANALYSIS OF FIRST-LINE PACLITAXEL WITH CARBOPLATIN AND BEVACIZUMAB FOLLOWED BY MAINTENANCE BEVACIZUMAB VERSUS PEMETREXED WITH CARBOPLATIN FOLLOWED BY MAINTENANCE PEMETREXED IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SM ...
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33579-4&doi=10.1016/j.jval.2018.09.279
First page :
Section Title :
Open access? : No
Section Order : 2126
Categories :
Tags :
Regions :
ViH Article Tags :